7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/22/2013

Company Name Symbol %Change
ALLIANCE FIB AFOP
9.31%
SONIC FOUNDR SOFO
7.77%
TRI TECH HOL TRIT
6.62%
A M R CP AAMRQ
4.52%
FLOWERS FOOD FLO
4.31%

CNO Financial Group (CNO)

by Zacks Equity Research

February 08, 2012 | Comments : 0 Recommended this article: (0)
CNO

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

We have downgraded our recommendation on CNO Financial Group (CNO) to Underperform based on the continuous deterioration in the premium revenue of its Bankers Life segment, coupled with the significant underwriting and pricing risks. The company's third-quarter earnings results were driven by poor top-line performance in most business segments.

The current interest rate environment, which is generating spread compression, will continue to put pressure on the bottom line. We do not expect any significant improvement on that front in the forthcoming quarters as the pricing pressure is expected to persist for awhile.

Our six-month target price of $5.75 equates to 7.9x our earnings estimate for 2011. This price target implies an expected negative total return of 10.9% over that period. This is consistent with our Underperform recommendation on the shares.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.